Literature DB >> 3299120

Antiproteinuric effect of captopril in primary glomerular disease.

G Lagrue, R Robeva, J Laurent.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1987        PMID： 3299120     DOI： 10.1159/000184318

Source DB:  PubMed          Journal:  Nephron        ISSN： 1660-8151            Impact factor:   2.847


× No keyword cloud information.
  7 in total

1.  Antiproteinuric effect of captopril in a patient with lupus nephritis and intractable nephrotic syndrome.

Authors:  Y Shapira; F Mor; A Friedler; A J Wysenbeek; A Weinberger
Journal:  Ann Rheum Dis       Date:  1990-09       Impact factor: 19.103

Review 2.  Angiotensin-converting enzyme inhibitors in chronic renal failure.

Authors:  J A Opsahl; P A Abraham; W F Keane
Journal:  Drugs       Date:  1990       Impact factor: 9.546

Review 3.  Angiotensin converting enzyme (ACE) inhibitors and renal function. A review of the current status.

Authors:  A L Kamper
Journal:  Drug Saf       Date:  1991 Sep-Oct       Impact factor: 5.606

4.  Differential effects of enalapril and atenolol on proteinuria and renal haemodynamics in non-diabetic renal disease.

Authors:  A J Apperloo; D de Zeeuw; H E Sluiter; P E de Jong
Journal:  BMJ       Date:  1991-10-05

5.  Renal effects of angiotensin converting enzyme inhibitors: nondiabetic chronic renal disease.

Authors:  J A Opsahl; P A Abraham; W F Keane
Journal:  Cardiovasc Drugs Ther       Date:  1990-02       Impact factor: 3.727

6.  Angiotensin converting enzyme inhibitors for reduction of proteinuria in children with steroid-resistant nephrotic syndrome.

Authors:  D S Milliner; B Z Morgenstern
Journal:  Pediatr Nephrol       Date:  1991-09       Impact factor: 3.714

Review 7.  Therapeutic Advances in Diabetic Nephropathy.

Authors:  Hanny Sawaf; George Thomas; Jonathan J Taliercio; Georges Nakhoul; Tushar J Vachharajani; Ali Mehdi
Journal:  J Clin Med       Date:  2022-01-13       Impact factor: 4.241
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.